Reliability of reverse transcription-polymerase chain reaction (RT-PCR)-based assays for the detection of circulating tumour cells: a quality-assurance initiative of the EORTC melanoma cooperative group
- 1 April 1998
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 34 (5) , 750-753
- https://doi.org/10.1016/s0959-8049(97)10105-8
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Polymerase chain reaction detection of circulating tumour cellsMelanoma Research, 1997
- Diagnostic PCR in melanoma, methods and quality assurance. Epalinges, Switzerland, 26/27 January 1996European Journal Of Cancer, 1996
- Peripheral Blood Tyrosinase Messenger RNA Detection and Survival in Malignant MelanomaJNCI Journal of the National Cancer Institute, 1996
- Polymerase Chain Reaction for Detection of Melanoma in Peripheral Blood: Too Early to Assess Clinical ValueJNCI Journal of the National Cancer Institute, 1996
- Detection and quantitation of melanoma cells in the circulation of patientsMelanoma Research, 1996
- A tyrosinase nonapeptide presented by HLA‐B44 is recognized on a human melanoma by autologous cytolytic T lymphocytesEuropean Journal of Immunology, 1996
- Detection of Residual Tumor Cells in Patients with Malignant Melanoma Responding to ImmunotherapyJournal of Immunotherapy, 1994
- Hematogenous Spread of Malignant Melanoma Cells in Different Stages of DiseaseJournal of Investigative Dermatology, 1993
- Reliability of polymerase chain reaction for detection of hepatitis C virusThe Lancet, 1993
- Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reactionThe Lancet, 1991